By proceeding, you agree to our Terms of Use and Privacy Policy.
The 2nd Next Generation RNA Therapeutics Summit is back, and it's the only industry event exclusively dedicated to advancing next generation RNA therapeutics and vaccines. The focus is on developing treatments that are more effective and have fewer off-target effects than first-generation RNA therapies, in order to speed up their therapeutic and commercial applications. At the summit, you can expect to hear from key opinion leaders (KOLs) who will share the latest updates on circRNAs, saRNAs, eRNAs, and tRNAs therapies. With over 100 thought leaders attending, including representatives from Pfizer, Orna Therapeutics, Laronde, Replicate Bioscience, and BioNTech, this is the perfect opportunity to stay ahead of the curve and maximize the full therapeutic potential of next generation RNA modalities. Join us to gain clinical proof of concept and bring these life-saving treatments to patients faster.
Discuss the current developments in next-generation RNA therapeutics and vaccines.
Learn from leading experts on RNA research, expand your knowledge of cutting-edge technologies and techniques, and explore new career opportunities.
Attend keynote sessions and panel dicussions by industry experts to discuss new ideas, strategies, developments and innovations in RNA research.
Listen to industry leaders, experts and professionals to leverage the therapeutic potential of next-generation RNA technologies and serve patients in need.
Hanson Wade gives people the clarity to see where opportunity lies. We work in highly specialised fields to provide unmatched depth and quality of content. We work in sectors where quality of information is the difference between success and failure.
Roche is a global pioneer in pharmaceuticals and diagnostics focused on advancing science to improve people’s lives.
Merck Life Sciences is a leader in biomarker immunoassays, including 200+ MILLIPLEX® multiplex kits with over 1,200 different analytes, for use with Luminex® instrumentation, an ultra-high sensitivity platform for Single Molecule Counting (SMC™), inc
Founded in 2019, Arranta Bio is a visionary contract development and manufacturing organization (CDMO) that partners with companies seeking to develop and manufacture complex biological drugs and innovative therapies.
Etherna (“the Company”), a leading mRNA technologies company, announced today that Antonin (Tony) de Fougerolles has joined its board of directors as an independent member.
Lipoid as the world's leading cGMP manufacturer of purified lecithins and phospholipids for pharmaceutical use. Lipoid produces natural purified lecithins and phospholipids derived from soy and egg.
Eclipsebio has developed multiple world-class RNA genomics products used by biopharma and academic customers around the world to map their RNA targets and RNA binding proteins with unmatched clarity.
At ChemGenes, we redefine the limits of scientific discovery, development and commercialization by manufacturing the broadest range of modified chemistries available in today’s market.
KACTUS is a biotechnology company serving global biopharma and diagnostics customers. We focus on commercial protein production for unmet needs in the drug development pipeline, including challenging recombinant proteins such as Claudin 18.2, MHC com
KACTUS is a biotechnology company serving global biopharma and diagnostics customers. We focus on commercial protein production for unmet needs in the drug development pipeline, including challenging recombinant proteins such as Claudin 18.2, MHC complexes, GPCR, CD20, and highly bioactive mRNA capp
All trademarks, registered trademarks, product names, and company names or logos mentioned in or on this site are the property of their respective owners.
A great community. Legit content. The kind of emails you actually look forward to.